跳至主要内容
临床试验/NCT04436926
NCT04436926已完成不适用

The Neural Basis of Approach Bias Modification in Opioid Users With Chronic Pain

University of California, San Francisco1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2021年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
Change in reaction time on an opioid approach-avoidance task across time, baseline to end of treatment, week 3

研究概览

简要总结

To investigate the neurobiological mechanisms underlying opioid approach bias during a pilot RCT of opioid approach bias modification. The investigators are combining novel ultra-high field MRI technology with the promising treatment of modifying cognitive bias away from detrimental prescription drug use will generate novel neural data and potentially yield a new therapeutic tool to reduce problematic opioid use.

详细描述

The proposed study is a pilot prospective, parallel groups, randomized, double blind, sham training-controlled, 6-session (over 2 weeks) clinical trial of opioid approach bias modification (OABM) in 20 male and female veterans with chronic pain at high risk for opioid-related adverse events at the San Francisco Veterans Affairs Health Care System, between ages 18-69. The study consists of screening, 2-week cognitive training, Week-3 post-assessment. Assessment of the neurobiological mechanisms of opioid approach bias will be administered at baseline and Week-3.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 69 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Male and female veterans eligible for VA services
  • •Ages 18-69
  • •Chronic pain (current pain lasting ≥ 90 days)
  • •Prescribed chronic opioids (≥ 90 days in past year)
  • •High risk for opioid-related averse outcomes (≥ 20mg morphine equivalent daily dose).

排除标准

  • •Psychotic, bipolar disorders or other psychiatric disorders judged to be unstable by the PI
  • •Current or past history of the following: intrinsic cerebral tumors, cerebrovascular accident/disease, brain aneurysm, arteriovenous malformations, surgical implantation of neurostimulators or cardiac pacemakers, demyelinating and neurodegenerative diseases, penetrating traumatic brain injury, and any other MRI contraindications.
  • •No female participant will be pregnant or actively attempting to conceive to prevent any unnecessary exposure to high magnetic fields or radio frequency energy to the unborn child.
  • •Concurrent participation in a treatment study
  • •Moderately Severe/Severe withdrawal from opioids based on a score of 25 or more on the Clinical Opiate Withdrawal Scale (COWS)

研究组 & 干预措施

opioid approach bias training

Experimental

Immediately following screening, patients will be randomly assigned to receive 6 sessions of opioid approach bias modification taking place over two weeks.

干预措施: opioid approach bias modification (Behavioral)

sham training

Sham Comparator

Immediately following screening, patients will be randomly assigned to receive 6 sessions of sham training taking place over two weeks.

干预措施: sham training (Behavioral)

结局指标

主要结局

Change in reaction time on an opioid approach-avoidance task across time, baseline to end of treatment, week 3

时间窗: baseline to end of treatment, week 3

millisecond reaction time of (opioid push - opioid pull) - (non-opioid push - opioid pull) on an opioid approach-avoidance task where participants are asked to respond to the format of presented pictures, irregardless of the content. There are two categories of pictures; 20 different opioid pictures and 20 different non-opioid pictures, with two-hundred trials. Millisecond reaction time will be measured at baseline, prior to each training session during the 2-week training period, and at week 3 post training assessment. Primary outcome is change in reaction time across time in active vs. sham condition.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Opioid Approach Bias Modification | 临床试验